Summer 1 2024: Epidemiological Research Methods in Infectious Diseases (001) laura.orsetti Wed, 01/17/2024 - 16:52
Anne C. Dietz, PhD, MS

Anne C. Dietz, PhD, MS

Associate Vice President, Epidemiology Oncology


Merck

 

Dr. Dietz currently leads a team of 19 cancer epidemiologists covering all major tumor types across early and late development. She previously was the Therapeutic Area Head of the Oncology team with eight reports covering GI, thoracic, head and neck, prostate cancers and melanoma. While in the role of Director of the Oncology team, she led a team of three reports. During her tenure at Merck, Dr. Dietz has received the Excel Award for Epi methods course planning for statisticians, the Impact Award for Leadership and Support of Keytruda ODAC preparations, as well as the Excel Award for outstanding leadership on the EXPRESS study and the Excellence Award for successful execution of FDA requested post-authorization safety study.


anne.deitz@merck.com

Dan T. Vogl, MD, MSCE

Dan T. Vogl, MD, MSCE

Associate Professor of Medicine


Division of Hematology and Oncology


University of Pennsylvania Perelman School of Medicine

 

Dr. Vogl’s research focus is on clinical trials of novel therapies plasma cell malignancies and specifically myeloma, with an emphasis on translational Phase I and II trials. He is the Director of the Abramson Cancer Center Clinical Research Unit, overseeing the work of over 90 research nurses, research coordinators, regulatory coordinators and biospecimen coordinators, who together manage over 300 active cancer clinical trials. Dr. Vogl has published in several high-impact journals such as the Cancer Research Communications and Clinical Cancer Research.

Dan.Vogl@pennmedicine.upenn.edu

 

 

Subscribe to